02/04/2020 12:00 AM EST
Source: U.S. Food and Drug Administration (FDA). Published: 2/4/2020. The potential for transmission of novel coronavirus (2019-nCoV) by blood and blood components is unknown at this time. This web page provides information for blood establishments from the Food and Drug Administration (FDA), which is aware that some blood establishments are considering donor education and/or donor deferral measures in response to 2019-nCoV. As a precaution, blood establishments may wish to consider whether to provide donor education, encourage self-deferral, and manage post-donation information about 2019-nCoV. (Text)
No hay comentarios:
Publicar un comentario